Literature DB >> 12711588

Information processing and movement optimization during development: kinematics of cyclical pointing in 5- to 11-year-old children.

Frédéric Bourgeois1, Laurette Hay.   

Abstract

The authors studied the development of movement control in speed-accuracy tradeoff conditions in children aged 5-11 years and in adults performing cyclical pointings. Twelve difficulty levels (IDs), ranging from 2 to 6.58 bits, were defined (P. M. Fitts, 1954). Peak and time to peak velocity, acceleration, and deceleration, and acceleration profiles as a function of hand position (Hooke's portraits) were analyzed. Movement time decreased with age and was less affected by ID. Peak velocity and acceleration increased, acceleration and deceleration were decreasingly time consuming, and movement profiles turned to increased harmonicity with age and task easiness. Nevertheless, the developmental trends differed between parameters. Gain in velocity seemed chiefly dependent on improved muscular cooperation patterns before 7 years of age and on improved information processing from age 7 onward; achievement of an optimized strategy in the speed-accuracy tradeoff occurred at age 11 years.

Entities:  

Mesh:

Year:  2003        PMID: 12711588     DOI: 10.1080/00222890309602132

Source DB:  PubMed          Journal:  J Mot Behav        ISSN: 0022-2895            Impact factor:   1.328


  2 in total

1.  Evaluation of Motor Skills in Children with Rubinstein-Taybi Syndrome.

Authors:  Jean René Cazalets; Emma Bestaven; Emilie Doat; Marie Pierre Baudier; Cécile Gallot; Anouck Amestoy; Manuel Bouvard; Etienne Guillaud; Isabelle Guillain; Emelyne Grech; Julien Van-Gils; Patricia Fergelot; Sonia Fraisse; Emmanuelle Taupiac; Benoit Arveiler; Didier Lacombe
Journal:  J Autism Dev Disord       Date:  2017-11

2.  Evaluation of the Leap Motion Controller during the performance of visually-guided upper limb movements.

Authors:  Ewa Niechwiej-Szwedo; David Gonzalez; Mina Nouredanesh; James Tung
Journal:  PLoS One       Date:  2018-03-12       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.